Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 65,14k | Derivative Exercise and Sale | 22,19 - 54,76 | 84,15k | - |
| 2026-05-15 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 43,42k | Derivative Exercise and Sale | 22,19 - 43,90 | 84,15k | - |
| 2026-04-15 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 35,42k | Derivative Exercise and Sale | 22,19 - 39,90 | 84,15k | - |
| 2026-03-13 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 26,50k | Derivative Exercise and Sale | 22,19 - 35,44 | 84,15k | - |
| 2026-02-13 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 29,50k | Derivative Exercise and Sale | 22,19 - 36,94 | 84,15k | - |
| 2026-02-15 | Mr. Thomas M. BuresCAO | -274,00 | 10,00k | Sale to Issuer | 36,51 | 969,00 | -22,04% |
| 2026-01-15 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 54,02k | Derivative Exercise and Sale | 22,19 - 49,20 | 84,15k | - |
| 2026-01-12 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -7,00k | 229,67k | Derivative Exercise and Sale | 22,19 - 55,00 | 84,15k | - |
| 2026-01-05 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -33,84k | 929,67k | Derivative Exercise and Sale | 22,19 - 50,00 | 84,15k | - |
| 2025-12-01 | Mr. Richard A. PackerLead Director | 4,97k | 119,33k | Derivative Exercise and Retained Stock | 24,00 | 85,88k | 6,15% |
| 2025-12-01 | Mr. Richard A. PackerLead Director | -5,03k | 122,56k | Derivative Exercise and Sale | 24,00 - 48,38 | 85,88k | - |
| 2025-11-06 | Mr. John A. OrnellIndependent Director | 3,77k | 90,41k | Derivative Exercise and Retained Stock | 24,00 | 31,91k | 13,38% |
| 2025-11-06 | Mr. John A. OrnellIndependent Director | -6,23k | 93,50k | Derivative Exercise and Sale | 24,00 - 39,00 | 31,91k | - |
| 2025-09-12 | Dr. Cynthia M. FriendInsider | 765,00 | 20,02k | Derivative Exercise and Retained Stock | 26,17 | 14,72k | 5,48% |
| 2025-09-12 | Dr. Cynthia M. FriendInsider | -3,54k | 21,48k | Derivative Exercise and Sale | 26,17 - 32,25 | 14,72k | - |
| 2025-08-09 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -3,73k | 113,83k | Sale to Issuer | 30,43 - 30,78 | 84,15k | -4,24% |
| 2025-08-09 | Mr. Gerald N. HermanExec. VP & CFO | -4,65k | 141,87k | Sale to Issuer | 30,43 - 30,78 | 56,20k | -7,64% |
| 2025-08-09 | Dr. Frank H. LaukienChairman, CEO & President | -12,92k | 394,76k | Sale to Issuer | 30,43 - 30,78 | 40,40M | -0,03% |
| 2025-08-05 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -844,00 | 27,07k | Sale to Issuer | 32,07 | 77,82k | -1,07% |
| 2025-08-05 | Dr. Frank H. LaukienChairman, CEO & President | -3,58k | 114,87k | Sale to Issuer | 32,07 | 40,38M | -0,01% |
| 2025-08-05 | Mr. Gerald N. HermanExec. VP & CFO | -577,00 | 18,50k | Sale to Issuer | 32,07 | 50,89k | -1,12% |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
